Bioaffinity Technologies, Stock Investor Sentiment

BIAF Stock  USD 0.38  0.05  15.15%   
Roughly 57% of all BioAffinity Technologies,'s stockholders are looking to take a long position. The analysis of the overall investor sentiment regarding bioAffinity Technologies, suggests that some traders are interested. The current market sentiment, together with BioAffinity Technologies,'s historical and current headlines, can help investors time the market. In addition, many technical investors use bioAffinity Technologies, stock news signals to limit their universe of possible portfolio assets.
  
six days ago at news.google.com         
How Will bioAffinitys 1.4M Capital Raise Impact Existing Shareholders - StockTitan
Google News at Macroaxis
over a week ago at businesswire.com         
Acquisition by Diamond Stuart of 33784 shares of BioAffinity Technologies, subject to Rule 16b-3
businesswire News
over a week ago at www.macroaxis.com         
Acquisition by Joyce Roby of 11867 shares of BioAffinity Technologies, at 1.58 subject to Rule 16b-3
Macroaxis News
over three weeks ago at thelincolnianonline.com         
bioAffinity Technologies Receives Notice Regarding Minimum Bid Price RequirementSAN ANTONIO, Texas b...
news
over three weeks ago at zacks.com         
Zacks Initiates Coverage of bioAffinity With Neutral Recommendation
zacks News
over a month ago at news.google.com         
Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money Sho...
Google News at Macroaxis
over a month ago at news.google.com         
bioAffinity Secures Australian Patent for Revolutionary Lung Cancer Detection Test - StockTitan
Google News at Macroaxis
over a month ago at news.google.com         
bioAffinity Technologies stock hits 52-week low at 0.65 - Investing.com
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
bioAffinity Technologies, Inc. Short Interest Down 35.8 percent in December
news
over a month ago at investing.com         
bioAffinity Technologies CEO receives salary increase
Investing News at Macroaxis
over a month ago at businesswire.com         
bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath Lung
businesswire News
over a month ago at www.macroaxis.com         
Acquisition by Zannes Timothy P of 8641 shares of BioAffinity Technologies, subject to Rule 16b-3
Macroaxis News
over two months ago at news.google.com         
bioAffinity Technologies Boosts Sales with CyPath Lung - Yahoo Finance
Google News at Macroaxis
over two months ago at businesswire.com         
Join bioAffinity Technologies Exclusive Live Investor Webinar and QA Session on Thursday, December 1...
businesswire News
over two months ago at finance.yahoo.com         
Join bioAffinity Technologies Exclusive Live Investor Webinar and QA Session on Thursday, December 1...
Yahoo News
Far too much social signal, news, headlines, and media speculation about BioAffinity Technologies, that are available to investors today. That information is available publicly through BioAffinity media outlets and privately through word of mouth or via BioAffinity internal channels. However, regardless of the origin, that massive amount of BioAffinity data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of BioAffinity Technologies, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BioAffinity Technologies, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BioAffinity Technologies,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BioAffinity Technologies, alpha.

BioAffinity Technologies, Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.15Dec2025Feb -60-40-200
JavaScript chart by amCharts 3.21.15bioAffinity Technologies, bioAffinity Technologies, Dividend Benchmark Dow Jones Industrial
       Timeline  

Complementary Tools for BioAffinity Stock analysis

When running BioAffinity Technologies,'s price analysis, check to measure BioAffinity Technologies,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies, is operating at the current time. Most of BioAffinity Technologies,'s value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies,'s price. Additionally, you may evaluate how the addition of BioAffinity Technologies, to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
News Freq…Investor S…